Elevated superoxide after MET treatment was previously described in hepatocellular carcinoma [43], and pancreatic cancer cells, where superoxide accumulation in the mitochondrial matrix was associated with alteration of superoxide dismutase (SOD) expression [16]. Here, SOD1 is linked to pancreatic neoplasm.